The Effects of Disease Management Programs for Prevention of Recurrent Ischemic Stroke

Active, not recruiting

Phase N/A Results N/A

Trial Description

It has been reported that stroke is the first cause of becoming bedridden, and its cumulative recurrence rate in 5 years is approximately 35%. There is a high probability that patients reduce or discontinue medications by self-determination, leading to a high risk of stroke recurrence in these patients. Comprehensive and long-term patient educations ameliorating their self-management are important making patients possible to be managed according to the guidelines for their risk factors. Using disease management programs created for each of risk factors according to clinical practice guidelines, the influence of those programs were evaluated for the prevention of stroke recurrence in this Disease Management Program Stroke Trial.

Conditions

Interventions

  • Usual care Other
    Intervention Desc: usual care group receive regular outpatient treatment
    ARM 1: Kind: Experimental
    Label: usual care
    Description: usual care group receive regular outpatient treatment
    ARM 2: Kind: Experimental
    Label: disease management
    Description: desease management program include self management education by nurse on 6months.
  • Disease management Other
    Other Names: Intervention of disease management program
    Intervention Desc: disease management program include self management education
    ARM 1: Kind: Experimental
    Label: disease management
    Description: desease management program include self management education by nurse on 6months.

Trial Design

  • Allocation: Randomized
  • Masking: Open Label
  • Purpose: Health Services Research
  • Intervention: Parallel Assignment

Outcomes

Type Measure Time Frame Safety Issue
Primary Stroke recurrence and Stroke death 2.5 years No
Secondary Framingham risk score: General cardiovascular disease 10-year risk 2.5 years No
Secondary body weight 2.5 years No
Secondary body mass index 2.5 years No
Secondary blood pressure 2.5 years No
Secondary cholesterol 2.5 years No
Secondary serum creatinine 2.5 years No
Secondary blood urea nitrogen 2.5 years No
Secondary glycated hemoglobin (HbA1c) 2.5 years No
Secondary blood glucose 2.5 years No
Secondary prothronbin time international rate 2.5 years No
Secondary The Center for Epidemiologic Depression Scale (CES-D) 2.5 years No
Secondary self-efficacy scale on health behavior in patient with chronic disease 2.5 years No
Secondary MOS 36-item short form (SF-36) 2.5 years No
Secondary Evaluated subject frequency of checking blood pressure 2.5 years No
Secondary Evaluated subject frequency of taking medicine 2.5 years No
Secondary Evaluated subject frequency of keeping the prescribed diet 2.5 years No
Secondary Evaluated subject frequency of exercising 2.5 years No
Primary Framingham Risk Score: general cardiovascular disease 10 year risk 2.5 years
Secondary Cumulative incidence rate of stroke recurrence and the complication (cardiovascular disease) 2.5 years
Secondary All-cause mortality 2.5 years
Secondary Mental Depression degree 2.5 years
Secondary self-efficacy degree 2.5 years
Secondary Qiality of Life (QOL) degree 2.5 years

Sponsors